Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Medicine » Immune Disorders » Autoimmune Disorders: Symptoms, Diagnosis and Treatment Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Automotive Cybersecurity: Issues and Vulnerabilities
$95.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266
Tell A Friend
 
Tell someone you know about this product.
Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266 $100.00
Authors:  (E.W. Brenu, L. Tajouri, D.R. Staines, S. Marshall-Gradisnik, Faculty of Health Science and Medicine, Population Health and Neuroimmunology Unit, Bond University, Robina, Queensland, Australia, and others)
Abstract:
Immunomodulation and immunosuppression are important strategies for monitoring autoimmune disorders. As imbalances in immune function affect other physiological processes, immunomodulators may have an important role in restoring and maintaining regular neuroimmue activities. In recent years these agents have demonstrated important benefits in controlling the mechanisms associated with deteriorating central nervous system pathologies such as Multiple Sclerosis (MS), where central and peripheral nervous system immune regulation is impaired. MS is characterized by severe compromises to neuroimmune processes involving changes in immune cell function, soluble proteins and modulation of inflammatory processes. The introduction of therapeutic agents in the form of immunomodulators; interferon, phosphodiesterase inhibitors and Glatiramer acetate have proven to be useful to some extent in reducing the severity of MS. Herein the implications and effects of these molecules on the immune system in MS are reviewed. Additionally, the available evidence on the mode of action of neuropeptides in MS, their effectiveness on clinical measures, and current knowledge are also reviewed. 


Available Options:
Version:
Special Focus Titles
01.Public Health: International Aspects on Environment and Health
02.Ageing and Mental Health: Global Perspectives
03.Alpha-Fetoprotein: Functions and Clinical Applications
04.Alternative Medicine: Perceptions, Uses and Benefits and Clinical Implications
05.Aluminum Neurotoxicity: From Subtle Molecular Lesions to Neurological Diseases
06.Accessing Justice through Mental Health Law Reform in the Pacific
07.The Fifty Most Influential Americans: Interviews with Professor Donald Elder III
08.Designing Optimal Models of Financial Regulation in a Changing Financial Environment
09.Growing Up in the Middle East: The Daily Lives and Well-Being of Israeli and Palestinian Youth
10.Praxeological Learning: Service-Learning in Teacher Education
11.Case Applications of Statistical Models in Ecology and Evolution
12.Psychology of Creativity: Cognitive, Emotional, and Social Processes

Nova Science Publishers
© Copyright 2004 - 2016

Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266